Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structural configuration supports high selectivity and binding affinity to specific enzyme targets. Commonly employed in the production of active pharmaceutical ingredients (APIs) requiring enantiomeric purity. Also utilized in research settings for asymmetric synthesis and medicinal chemistry optimization due to its stability and reactivity profile.